Related Experiment Videos
Metrizamide in neonatal and childhood small bowel obstruction
Insights
Metrizamide (Amipaque) offers a new imaging method for neonates and children with suspected bowel obstruction when other agents are contraindicated. This technique provides crucial information, altering patient management and distinguishing between ileus and mechanical obstruction.
Area of Science:
- Radiology
- Pediatric Imaging
- Gastrointestinal Imaging
Background:
- Barium and hypertonic agents are often contraindicated in neonates and children with suspected bowel obstruction.
- Accurate diagnosis is crucial for appropriate management of pediatric gastrointestinal issues.
Observation:
- Metrizamide (Amipaque) was used to image the bowels of four neonates and one older child.
- These patients had contraindications for standard contrast agents like Gastrografin and Hypaque.
Findings:
- Metrizamide imaging provided unique, actionable information in all cases.
- The studies directly influenced patient management decisions.
Implications:
- Metrizamide presents a novel approach for evaluating challenging cases of suspected neonatal bowel obstruction.
- In older children, it aids in differentiating postoperative ileus from mechanical obstruction.
Abstract:
Metrizamide (Amipaque) has been used to image the bowel of four neonates and one older child with possible bowel obstruction. In each case, barium and hypertonic water-soluble agents, such as Gastrografin and Hypaque, were contraindicated. In each case, the metrizamide study provided unique formation altering the management of the patient. Metrizamide provides a new method of evaluating selected difficult cases of suspected bowel obstruction in the newborn, and in older children it may help to distinguish between postoperative ileus and mechanical obstruction.